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Summary
Burkholderia cenocepacia is an important pulmonary
pathogen in individuals with cystic fibrosis (CF). Infec-
tion is often associated with severe pulmonary inflam-
mation, and some patients develop a fatal necrotizing
pneumonia and sepsis (‘cepacia syndrome’). The
mechanisms by which this species causes severe
pulmonary inflammation are poorly understood. Here,
we demonstrate that B. cenocepacia BC7, a potentially
virulent representative of the epidemic ET12 lineage,
binds to tumour necrosis factor receptor 1 (TNFR1)
and activates TNFR1-related signalling pathway
similar to TNF-a, a natural ligand for TNFR1. This
interaction participates in stimulating a robust IL-8
production from CF airway epithelial cells. In contrast,
BC45, a less virulent ET12 representative, and ATCC
25416, an environmental B. cepacia strain, do not bind
to TNFR1 and stimulate only minimal IL-8 production
from CF cells. Further, TNFR1 expression is increased
in CF airway epithelial cells compared with non-CF
cells. We also show that B. cenocepacia ET12 strain
colocaizes with TNFR1 in vitro and in the lungs of CF
patients who died due to infection with B. cenocepa-
cia, ET12 strain. Together, these results suggest that
interaction of B. cenocepacia, ET12 strain with TNFR1
may contribute to robust inflammatory responses elic-
ited by this organism.
Introduction
Cystic fibrosis (CF) is caused by mutations in the gene
encoding the CF transmembrane conductance regulator
(Riordan et al., 1989; Rommens et al., 1989). Chronic
lung disease accounts for most of the morbidity and mor-
tality in CF, and is characterized by airway obstruction,
chronic bacterial infection and vigorous inflammation that
results in bronchiectasis and eventual pulmonary failure.
Although Pseudomonas aeruginosa is the most common
respiratory pathogen in CF, Burkholderia cenocepacia, a
member of B. cepacia complex (Bcc), is as an important
opportunistic pathogen associated with increased rates of
morbidity and mortality. B. cenocepacia-infected patients
show an unpredictable and variable clinical course,
ranging from asymptomatic carriage to fatal necrotizing
pneumonia and sepsis (‘cepacia syndrome’) (Isles et al.,
1984). Among the epidemic lineages of B. cenocepacia,
the ET12 lineage appears to be disproportionately asso-
ciated with cepacia syndrome-related deaths (Ledson
et al., 2002), and patients infected with this strain are at
especially high risk of poor outcome after lung transplan-
tation (De Soyza et al., 2001; 2004a).
Although pulmonary inflammation is a critical element
of host defence, it also contributes significantly to the lung
damage that is a hallmark of CF. Pathogens that are
capable of inducing an intense and sustained chemokine
response from the airway epithelium likely add to the
severity of lung disease in CF. Bacterial products from
both P. aeruginosa and members of the Bcc stimulate an
excessive and prolonged pro-inflammatory response in
epithelial cells and/or monocytes; however, products from
Bcc species are more potent inducers of this response
than P. aeruginosa (Shaw et al., 1995; Zughaier et al.,
1999; Kube et al., 2001).
Epithelial cells lining the airway mucosa express
several cell surface receptors, including evolutionarily
conserved toll-like receptors (TLRs). These receptors rec-
ognize particular molecular patterns of invading patho-
gens and signal cells to respond appropriately by
expressing neutrophil-attracting C-X-C chemokines,
including IL-8, which is required for effective clearance of
pathogens (Bals and Hiemstra, 2004). P. aeruginosa-
induced stimulation of IL-8 from CF airway epithelial cells
involves interaction of whole bacteria or bacterial compo-
nents (pili, flagella or exoenzyme) with asialo-GM1 and
TLRs 2, 4 and 5 (Bryan et al., 1998; Adamo et al., 2004;
Epelman et al., 2004; Soong et al., 2004). Similarly,
members of the Bcc interact with TLRs 4 and 5 and
activate downstream signalling pathways, leading to IL-8
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production (Reddi et al., 2003; Urban et al., 2004). Bac-
terial ligands responsible for this interaction were identi-
fied as lipopolysaccharide (LPS) and flagella, which are
common to all members of the Bcc. We and others have
shown that B. cenocepacia stimulates a greater pro-
inflammatory response than the other species of Bcc in
airway epithelial cells (Palfreyman et al., 1997; Fink et al.,
2003; Sajjan et al., 2004). More recently, the lipid A moiety
from LPS, a key determinant of pro-inflammatory poten-
tial, was shown to vary among B. cenocepacia isolates,
with the lipid A from B. cenocepacia strain BC7 being a
relatively weak cytokine inducer in monocytic cell lines
(De Soyza et al., 2004b). BC7 was originally isolated from
a patient who died of ‘cepacia syndrome’, and is capable
of stimulating relatively high IL-8 production from CF bron-
chial epithelial cells and causing intense inflammation in
infected CF mice (Sajjan et al., 2001a; 2004). These
observations suggest that, although the interaction of
B. cenocepacia components (LPS, lipid A or flagella) with
TLRs 4 and 5 plays a significant role in stimulating
chemokine responses in monocytes and pneumocytes, it
may not explain the robust inflammatory response elicited
by B. cenocepacia BC7 in CF bronchial epithelial cells.
Therefore, we hypothesized that B. cenocepacia BC7
binds to yet other undefined receptors on CF bronchial
epithelial cells to activate downstream signalling events
that leads to the production of IL-8, a potent neutrophil
chemoattractant. To test this hypothesis, a cell surface
receptor that interacts particularly with B. cenocepacia
BC7 was identified and the contribution of this interaction
to the pro-inflammatory response in CF airway epithelial
cells was investigated.
Results
Burkholderia cenoceapcia BC7 binds to tumour necrosis
factor (TNF) receptor 1 (TNFR1)
Previously, we have shown that B. cenocepacia BC7
stimulates greater IL-8 production in well-differentiated CF
primary airway epithelial cells than in similarly grown
non-CF cells (Sajjan et al., 2004). To identify the cell
surface receptor that mediates this response, plasma
membrane proteins corresponding to 25 mg of total
protein from CF epithelial cells were resolved by SDS-
PAGE and transferred to nitrocellulose. Membranes were
incubated with 35S-labelled BC7, and bound bacteria were
detected by autoradiography. ATCC 25416, an environ-
mental B. cepacia strain, and BC45, an ET12 strain
obtained from a patient with no apparent change in
disease severity, were used as negative controls,
because these strains stimulated only minimal IL-8 pro-
duction from CF airway epithelial cells. A major protein
band at 55 kDa was observed in membranes incubated
with BC7, along with a few minor bands (Fig. 1A). Under
these experimental conditions, neither BC45 nor ATCC
25416, which stimulate only minimal IL-8 production from
CF airway epithelial cells (Sajjan et al., 2004), bound to
the 55 kDa protein. The differences in bacterial binding
could not be attributed to differential protein loading, as
Ponceau staining of the membrane before incubation with
bacteria showed equal amounts of protein in each lane
(data not shown). To examine whether denaturing condi-
tions prevent the identification of other receptor proteins,
we carried out a similar binding experiment after resolving
the plasma membrane proteins under native conditions.
Only the blot incubated with BC7 showed a smear at the
top, indicating retention of membrane proteins in the
stacking gel (data not shown). These results suggest that
denaturing conditions do not prevent bacteria from
binding to its receptor and, in fact, facilitates identification
of specific receptors. We then sought to determine the
identity of 55 kDa protein that specifically interacts with
BC7. Protein bands at the 55 kDa position were cut out
from an identical gel prepared from plasma membrane
protein fraction (which was not processed for bacterial
binding) and subjected to in-gel trypsin digestion followed
by tandem mass spectrometry (MS/MS) analysis. We
obtained the amino acid sequence for seven peptides,
three of which matched the amino acid sequence of
TNFR1, suggesting that TNFR1 is one of the putative
cellular receptors for BC7.
To confirm the receptor identity, plasma membrane
blots were pre-incubated with a monoclonal antibody to
TNFR1 or normal mouse IgG (negative control), followed
by 35S-labelled BC7, and the bound bacteria were
detected by autoradiography. Both normal mouse IgG and
TNFR1 antibody increased the binding of BC7 to the
55 kDa receptor, probably due to non-specific interactions
(data not shown). Similar results were obtained when a
polyclonal antibody to TNFR1 was used instead of a
monoclonal antibody; thus it was not possible to deter-
mine the inhibitory effect of TNFR1 antibody on the
binding of BC7 to the 55 kDa receptor. Next, we examined
the effects of recombinant non-glycosylated TNFR1 and a
TNFR1/Fc chimera, in which Fc portion is glycosylated on
the binding of bacteria to TNFR1. Both recombinant mol-
ecules failed to inhibit the binding of BC7 to natural
TNFR1 (data not shown). These results suggest that gly-
cosylation of TNFR1 (and not on the Fc carrier molecule)
may be required for bacteria to recognize its receptor.
These results prompted us to examine the inhibitory effect
of TNF-a, which is a natural ligand for TNFR1.
Initially, we examined whether TNF-a binds to the dena-
tured TNFR1 by overlay assay. Blots of plasma mem-
brane protein fraction and recombinant TNFR1/Fc
chimera were either subjected to Western blot analysis
with a monoclonal antibody to TNFR1, or incubated with
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TNF-a, and the bound TNF-a was detected by using a
polyclonal antibody to TNF-a. Antibody to TNFR1
detected a band at 55 kDa in the plasma membrane
protein fraction. Recombinant TNFR1/Fc chimera was
detected at a slightly higher position (Fig. 1B). Although
the molecular weight of TNFR1/Fc chimera is 48 kDa, the
recombinant protein migrates as a 60 kDa protein as a
result of glycosylation in the Fc portion, according to the
manufacturer’s information sheet (R&D Systems). Nearly
identical bands were observed in blots incubated with
TNF-a, confirming that TNF-a binds to denatured TNFR1
and could be used to inhibit the binding of BC7 to TNFR1
(Fig. 1C). TNF-a also binds to TNFR2, which has a
molecular weight of 75 kDa. Absence of a positive band at
this position in plasma membrane protein fraction was not
surprising, because airway epithelial cells do not express
TNFR2 (Gomez et al., 2004).
To assess the effect of TNF-a on the binding of BC7 to
TNFR1, blots of epithelial cell plasma membrane fraction
were pre-incubated with TNF-a or IL-1b, incubated with
35S-labelled BC7, and the bound bacteria detected by
autoradiography. TNF-a inhibited the binding of BC7 to
TNFR1 in a dose-dependent manner and almost com-
pletely abrogated the binding at a concentration of
5 mg ml-1 (Fig. 1D). In contrast, IL-1b had no effect on the
binding of BC7 to TNFR1 even at the highest concentra-
tion used. These results suggest that TNF-a receptor
(TNFR1) may function as a receptor for BC7.
Tumour necrosis factor receptor 1 (TNFR1) expression
is increased in primary cultures of CF airway
epithelial cells
Airway epithelial cells obtained from two CF and two
non-CF individuals were cultured at an air/liquid interface.
Total protein extracts from these cells were subjected to
immunoblot analysis using TNFR1 antibody (Fig. 2A).
Compared with non-CF cells, CF airway epithelial cells
showed more intense 55 kDa immunoreactive bands,
although intensity of b-actin bands was similar in each
lane, an indication of increased expression of TNFR1 in
CF cells. To determine the distribution of TNFR1, paraffin
sections of CF and non-CF cultures were immunostained
with antibody to TNFR1. Both CF and non-CF cells
expressed TNFR1, but there was a difference in distribu-
tion of this receptor in these cell types. CF cells appear to
have more TNFR1 on the cell membrane (Fig. 2B and C).
Sections incubated with normal mouse IgG (negative
Fig. 1. Identification of cellular receptor for B. cenocepacia.
A. Binding of bacteria to 55 kDa protein. A fraction enriched in membrane proteins prepared from CF airway epithelial cells differentiated into a
mucociliary phenotype was subjected to SDS-PAGE. Proteins were transferred to a nitrocellulose membrane, blocked with gelatin, incubated
with 35S-labelled bacteria, and bound bacteria were detected by autoradiography.
B and C. Binding of TNF-a to denatured TNFR1. Denatured plasma membrane fraction or TNFR1/Fc chimera was subjected to SDS-PAGE,
and proteins were transferred to nitrocellulose. Blots were either subjected to Western blot analysis with monoclonal antibody to TNFR1 (B), or
incubated with TNF-a, and the bound protein was detected by using polyclonal antibody to TNF-a (C).
D. Inhibition of BC7 binding to 55 kDa protein by TNF-a. Blots of plasma membrane proteins were pre-incubated with TNF-a or IL-1b, followed
by incubation with 35S-labelled bacteria. Bound bacteria were detected by autoradiography and semiquantified by densitometry.
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control) instead of TNFR1 antibody were negative, indi-
cating the specificity of the antibody (Fig. 2D and E).
Tumour necrosis factor receptor 1 functions as a
receptor for BC7 in airway epithelial cells
To determine the role of TNFR1 as a receptor for
B. cenocepacia in intact cells, we used immortalized CF
(IB3) cells, because these cells retain the characteristics
of CF cells and, at the same time, do not produce mucus,
which might hinder the accessibility of cell surface mol-
ecules to potential inhibitors. TNFR1 expression on the
surface of IB3 cells was confirmed by fluorescence-
assisted cell sorting (FACS) analysis. Non-permeabilized
IB3 cells incubated with a TNFR1 antibody showed
increased fluorescence as indicated by shift in the histo-
gram to the right (Fig. 3A) compared with normal IgG-
treated cells (control), suggesting that IB3 cells express
abundant amounts of TNFR1 on their surface. Bacterial
binding to cells was then determined by incubating IB3
Fig. 2. Expression of TNFR1 in CF and
non-CF airway epithelial cells.
A. Western blot analysis. Cell lysates from CF
and non-CF primary airway epithelial cells
differentiated into a mucociliary phenotype
were probed with monoclonal antibody to
TNFR1. N1 and N2 are normal airway
epithelial cells from two different donors; CF1
and CF2 are airway epithelial cells from two
different CF patients.
B–E. Immunofluorescence detection of
TNFR1. Paraffin-embedded sections prepared
from CF (C) and non-CF (B) mucociliary
cultures were stained with monoclonal
antibody to TNFR1, and the bound antibody
was detected by anti-mouse IgG conjugated
with Alexa Fluor-598. Arrowheads represent
TNFR1 expression on the apical surface.
Sections stained with normal IgG are shown
in D and E.
Fig. 3. Binding of bacteria to TNFR1 in intact
cells.
A. Expression of TNFR1: non-permeabilized
IB3 cells were incubated with monoclonal
antibody to TNFR1, and bound antibody was
detected with anti-mouse IgG conjugated with
Alexa Fluor-488 and analysed by FACS. Data
presented are representative of three
independent experiments.
B. Binding of bacteria to cells: IB3 cells were
lightly fixed with 0.5% paraformaldehyde,
washed and incubated with FITC-labelled
BC7 or ATCC 25416. Cells were harvested
after removal of unbound bacteria and
analysed by FACS. Data presented are
representative of three independent
experiments.
C and D. Effect of TNF-a or TNFR1 antibody
on binding of bacteria to IB3 cells: lightly fixed
IB3 cells were incubated with TNF-a or
TNFR1 antibody for 30 min, followed by
incubation with FITC-labelled BC7. Bacterial
binding was then assessed by FACS. Data
represent mean  SEM of four independent
experiments carried out in triplicates;
*P < 0.05, ANOVA.
Interaction of B. cenocepacia with TNFR1 191
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 10, 188–201
cells with fluorescein isothiocyanate (FITC)-labelled BC7
or ATCC 25416, followed by FACS analysis. Only cells
incubated with BC7 showed a shift in the histogram, indi-
cating that BC7, but not ATCC 25416, binds to IB3 cells
(Fig. 3B). Pre-incubation of IB3 cells with TNF-a, a natural
ligand for TNFR1 (Fig. 3C), and antibody to TNFR1
(Fig. 3D), each inhibited the binding of BC7 to IB3 cells in
a dose-dependent manner, with maximum reductions of
43% and 45% respectively, indicating that TNFR1 may
serve as a cellular receptor for BC7. IL-1b or normal IgG,
which were used as negative controls, had no effect on
BC7 binding to IB3 cells (data not shown). The partial
inhibition of BC7 binding to epithelial cells by TNF-a con-
trasts with previous results, in which TNF-a completely
inhibited BC7 binding to TNFR1 (Fig. 1D), because in this
experiment, the binding of BC7 to isolated TNFR1 was
being determined rather than the intact cells. Taken
together, these data suggest that in intact cells, BC7 may
also bind to other cellular receptors in addition to TNFR1.
BC7 colocalizes with TNFR1 in cell cultures
differentiated into mucociliary phenotype
Well-differentiated CF and normal cell cultures were incu-
bated with BC7 and incubated for 2 h. Cell cultures were
washed to remove unbound bacteria, fixed and embed-
ded in paraffin. Thin sections from these cultures
were immunostained with antibodies to TNFR1 and
B. cenocepacia and visualized by confocal fluorescence
microscopy, taking optical sections at 0.2 m intervals. In
general, CF cell cultures showed more bound bacteria
than the similarly treated normal cells, as observed pre-
viously (Sajjan et al., 2004). Further, at least 40–50% of
the bound bacteria colocalized with TNFR1 in both CF
and normal cells (Fig. 4C and D).
Colocalization of B. cenocepacia with TNFR1 in CF and
normal lung sections
Paraffin sections prepared from lungs of a CF patient
who died due to infection with B. cenocepacia ET12,
were immunostained with antibodies to TNFR1 and
B. cenocepacia (Figs 5C–F). Lung sections obtained from
a normal donor served as a negative control (Fig. 5A and
B). CF lung sections showed increased expression
of TNFR1 compared with normal lung sections.
As expected, normal lung sections did not show
B. cenocepacia (Fig. 5B). On the other hand, CF sections
showed B. cenocepacia organisms in both the airways
and parenchyma, which frequently colocalized with
TNFR1 in bronchial and alveolar epithelial cells (Fig. 5D
and F). The B. cenocepacia isolate (BCM132) obtained
from this patient belongs to ET12 lineage as determined
by PFGE analysis. It showed binding to 55 kDa TNFR1
and also stimulated IL-8 from CF cells similar to BC7
(Fig. 6A and B). These observations suggest that
B. cenocepacia ET12 may interact with TNFR1 in the
lungs of infected CF patients.
Burkholderia cenocepacia BC7 activates TNFR1-related
signalling pathway
We sought to examine the pro-inflammatory signalling
pathways activated by BC7 in CF airway epithelial cells.
Fig. 4. Colocalization of B. cenocepacia BC7 with TNFR1 in non-CF and CF cell cultures: Paraffin sections of non-CF (A and C) and CF (B
and D) primary cultures infected with BC7 were incubated with antibodies to TNFR1 and B. cenocepacia, and the bound antibodies were
detected by Alexa Fluor-488 (for detection of TNFR1) and anti-rabbit Alexa Fluor-598 (for detection of bacteria). Arrowheads in C and D
indicate colocalization of bacteria with TNFR1. A and B are phase-contrast micrographs and correspond to C and D respectively. The inset in
D is a digital magnification of an area marked in rectangle to show colocalization of bacteria with TNFR1 (yellow).
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Fig. 5. Colocalization of B. cenocepacia with
TNFR1 in lungs of a CF patient. Lung
sections from normal donor (A and B) or a CF
patient who died due to B. cenocepacia
infection (C–F) were incubated with antibodies
to TNFR1 and B. cenocepacia, and the bound
antibody was detected as described in Fig. 4.
A, C and E are phase-contrast micrographs
and correspond to B, D and F respectively.
Arrowheads indicate colocalization of bacteria
with TNFR1. The inset in D and F is a digital
magnification of an area marked in rectangle
to demonstrate colocalization of bacteria with
TNFR1 (yellow) in the lung sections.
Fig. 6. A. Binding of BCM132 to 55 kDa
TNFR1. Western blots of plasma membrane
proteins were either incubated with
35S-labelled BCM132 or BC7. Bound bacteria
were detected by autoradiography.
B. Stimulation of IL-8 response in IB3 cells by
BCM132. IB3 cells were incubated with
BCM132 or BC7 at a moi of 0.1 for 24 h, and
the IL-8 in cell culture media was measured
by ELISA. *P < 0.05, ANOVA.
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IB3 cells were utilized in this study, because these cells
can be transfected readily compared with primary cells
and also we have established that TNFR1 in IB3 cells
functions as one of the receptors for BC7. To assess
whether IB3 cells respond to BC7 infection similar to
primary cells (Sajjan et al., 2001a; 2004), IB3 cells were
incubated with BC7 or ATCC 25416, and IL-8 protein
measured by ELISA, at 1–24 h post infection. IB3 cells
incubated with BC7 produced more IL-8 protein than cells
incubated with ATCC 25416 at all time points (Fig. 7A),
and IL-8 protein level corresponded to number of bacteria
associated with cells (Fig. 7B). UV- or heat-killed BC7
stimulated significantly less IL-8 production than viable
bacteria (Fig. 7C), indicating that infection of cells by bac-
teria is required for maximum IL-8 production.
Because airway epithelial cells may release TNF-a in
response to infection, we tested whether BC7-stimulated
IL-8 production in IB3 cells was mediated by TNF-a. IB3
cells were incubated with bacteria in the presence of
TNF-a neutralizing antibody or normal IgG (negative
control), and IL-8 protein was again measured. To confirm
the neutralizing activity of the TNF-a antibody, TNF-a was
used as a positive control. TNF-a neutralizing antibody
completely inhibited TNF-a-stimulated IL-8 production, at
a concentration as low as 50 ng ml-1 (Fig. 7D). In contrast,
BC7-stimulated IL-8 expression was not affected by
TNF-a neutralizing antibody, even at 1 mg ml-1 (Fig. 7E).
Normal IgG did not affect the expression of IL-8 stimu-
lated by either TNF-a or BC7, indicating the specificity
of TNF-a neutralizing antibody. Together, these results
suggest that BC7-stimulated IL-8 production in IB3 cells is
not mediated by TNF-a, but rather occurs as a result of
direct interaction between BC7 and TNFR1.
Binding of TNF-a to TNFR1 induces receptor trimeriza-
tion and recruitment of the TNF receptor-associated death
domain protein (TRADD). TRADD in turn acts as a platform
and recruits TNF receptor activating factor 2 (TRAF2) and
receptor interacting protein 1 (RIP1). This process then
activates NF-kB via mitogen-activated protein kinases p38
and c-jun N-terminal kinases 1 and 2, ultimately leading to
IL-8 production (Baud and Karin, 2001; Gomez et al.,
2004). As a next step, we examined whether binding
of BC7 to TNFR1 activates TNFR1-related signalling
pathway, similar to TNF-a in CF airway epithelial cells. IB3
cells were incubated with TNF-a (3 ng ml-1), BC7 or ATCC
25416 [each at a multiplicity of infection (moi) of 10] for 5,
15 or 30 min. Cell lysates were immunoprecipitated with a
TNFR1 antibody , and the immunoprecipitates were sub-
jected to Western blot analysis with antibody to TRADD or
RIP1. Control cells or cells incubated with ATCC 25416 did
not show receptor complex formation (Fig. 8A). In contrast,
both TNF-a and BC7 induced recruitment of TRADD and
RIP1 within 5 min, and it persisted up to 30 min. The
binding of TNF-a or BC7 to TNFR1 also activated mitogen-
activated protein kinases p38 and Jun amino-terminal
kinase 1/2 (JNK1/2) in IB3 cells as indicated by phospho-
rylation of these two kinases (Fig. 8B and C). Cells incu-
bated with ATCC 25416 or control cells did not show
phosphorylation of either p38 or JNK1/2. Incubation of cells
with UV- or heat-killed BC7 did not cause phosphorylation
of p38 or JNK1/2 (Fig. 8D), indicating that either these
treatments destroyed the bacterial ligand or infection with
live bacteria is necessary for binding and activation of
TNFR1 signalling pathway. These results suggest that BC7
activates a TNFR1-associated signalling pathway, similar
to TNF-a in CF cells.
Tumour necrosis factor receptor 1 (TNFR1) siRNA
partially inhibits transactivation of NF-kB by
B. cenocepacia BC7
IB3 cells were co-transfected with cDNAs encoding
NF-kB-luciferase and renilla luciferase, and incubated
with BC7 or ATCC 25416. TNF-a-treated cells served as
positive controls and showed increased NF-kB transacti-
vation as expected. Cells incubated with BC7 showed
5.9-fold mean increases in NF-kB transactivation, a
significantly greater response than control cells or cells
incubated with ATCC 25416 (Fig. 9A). These results sug-
gested that BC7-stimulated IL-8 production in IB3 cells is
accompanied by NF-kB transactivation.
To assess the contribution of TNFR1 in BC7-stimulated
NF-kB transactivation, we used a mononoclonal antibody
to TNFR1, which significantly inhibited the binding of BC7
to TNFR1 (Fig. 4) or TNFR1 siRNA to decrease or abolish
the expression of TNFR1. IB3 cells transfected with
NF-kB-luciferase and renilla luciferase were pre-
incubated with a TNFR1 antibody or normal IgG, and B.
cenocepcia-stimulated NF-kB transactivation was mea-
sured as before. TNFR1 antibody, by itself, caused NF-kB
transactivation (data not shown) probably by ligating
to TNFR1 and activating the downstream signalling
pathway. Hence, TNFR1 antibody could not be used to
determine the contribution of TNFR1 in BC7-induced
transactivation of NF-kB.
IB3 cells were transfected with TNFR1 or non-targeting
siRNA at 0, 20 or 40 pmol, and the expression of TNFR1
was determined by Western blot analysis. TNFR1-
specific, but not non-targeting siRNA, reduced the expres-
sion of TNFR1 at both concentrations to a similar extent
(Fig. 9B). Based on these results, we used 20 pmol of
siRNA in subsequent experiments. IB3 cells were
co-transfected with TNFR1 or non-targeting siRNA,
NF-kB-luciferase and renilla luciferase, and BC7-
stimulated NF-kB transactivation was measured as
before. TNF-a and ATCC 25416 were used as positive
and negative controls respectively. TNFR1-specific siRNA
inhibited TNFa-stimulated NF-kB transactivation by
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Fig. 7. Effect of TNF-a neutralizing antibody on B. cenocepacia-stimulated IL-8 response in IB3 cells.
A. IL-8 response: IB3 cells were incubated with B. cenocepacia BC7 or ATCC 25416 for 1, 3, 6 or 24 h, and IL-8 in the cell culture media was
quantified by ELISA.
B. Binding of bacteria to cells. Cells incubated with bacteria for 3, 6 or 24 h were fixed, and bacteria associated were immunostained with Bcc
antibody and quantified by immunofluorescence microscopy.
C. IL-8 response to UV- or heat-killed BC7: IB3 cells were incubated with live, UV-killed or heat-killed BC7 for 24 h, and IL-8 in the cell culture
media was quantified by ELISA.
D and E. Effect of TNF-a neutralizing antibody: IB3 cells were incubated with 3 ng of TNF-a (D) or B. cenocepacia BC7 at a moi of 0.1 (E) in
the presence or absence of varying concentrations of TNF-a neutralizing antibody or normal IgG for 24 h. IL-8 in cell culture supernatants was
quantified by ELISA. Bars represent mean  SEM of four independent experiments carried out in triplicate; *P < 0.05, ANOVA.
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almost 90%, indicating that TNF-a-driven NF-kB transac-
tivation is dependent on TNF-a ligation to TNFR1 under
the present experimental conditions. BC7-stimulated
NF-kB transactivation was partially inhibited by TNFR1-
specific siRNA (Fig. 9C), suggesting that binding of BC7
to TNFR1 is required for maximal BC7-stimulated cell
activation. Non-targeting siRNA did not affect NF-kB
transactivation stimulated by either TNF-a or BC7, indi-
cating the specificity of TNFR1-siRNA. ATCC 25416-
induced transactivation of NF-kB was not affected by
either TNFR1-siRNA or non-targeting siRNA. Taken
together, these results suggest that TNFR1 may function
as one of the cellular receptors for potentially virulent
ET12 strains of B. cenocepacia, and this binding interac-
tion contributes to the robust IL-8 response from CF
airway epithelial cells.
Fig. 8. Activation of TNFR1-related signalling
pathway by B. cenocepacia.
A. Western blot analysis of
immunoprecipitates: IB3 cells were incubated
with either TNF-a (3 ng ml-1) or
B. cenocepacia, BC7 or ATCC 25416 at a moi
of 10 for 5, 15 or 30 min and lysed. Cell
lysates were immunoprecipitated with a
TNFR1 antibody and subjected to Western
blot analysis with either TRADD or RIP1
antibody.
B and C. Phosphorylation of p38 and JNK:
lysates from the same experiment were
subjected to immunoblot analysis with
antibodies to phosho-p38, or total p38 (B)
phospho-JNK1/2, or total JNK1/2 (C).
D. Phosphorylation of p38 and JNK in IB3
cells incubated with heat-killed or UV-killed
BC7: cell lysates from IB3 cells incubated with
live, UV- or heat-killed bacteria for 30 min
were subjected to immunoblot analysis with
antibodies to phosho-p38, or total p38
phospho-JNK1/2, or total JNK1/2 (D). Data
presented are representative of three
independent experiments. Std, molecular
mass standards; cell lysate: total-cell lysate
was used to confirm the band positions of
TRADD or RIP1 observed in
immunoprecipitates; Con, untreated IB3 cells.
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Discussion
Previously, we demonstrated that the interaction of
BC7 with cytokeratin 13 (CK13) influenced the pro-
inflammatory response from squamous epithelial cells
(Sajjan et al., 2000a; 2002). While CK13 is normally
expressed in nasal mucosa and trachea, expression is
increased in the lower airway epithelium after repeated
injury, which is common in CF lungs (Moll et al., 1982;
Nagle et al., 1985; Sajjan et al., 2000b). However, we
also showed that B. cenocepacia BC7 can stimulate
intense and sustained IL-8 production in CF airway epi-
thelial cells differentiated into a mucociliary phenotype,
which do not express CK13 on their apical surface
(Sajjan et al., 2004). We further observed that B. ceno-
cepacia interacts with alveolar epithelial cells in the
lungs of CF patients, where CK13 expression was not
evident (Sajjan et al., 2000b; 2001b). TLR4 and TLR5
have been shown to be potential receptors for B. ceno-
cepacia LPS and flagella respectively (Reddi et al.,
2003; Urban et al., 2004). However, in preliminary
studies, we observed that HEK293 cells, which lack
TLRs, responded to infection with BC7 by producing IL-8
(data not shown). Together, these observations sug-
gested that BC7 interacts with a receptor other than
CK13 or TLRs in CF airway epithelial cells.
In this study, we demonstrated that BC7, one of the
potentially virulent ET12 strains of B. cenocepacia, binds
to TNFR1 and this binding interaction induces association
of TNFR1 with TRADD and RIP, as well as activation of
p38 and JNK, similar to the receptor’s natural ligand
TNF-a. Further, we found that TNFR1 siRNA partially
inhibited NF-kB transactivation stimulated by BC7. Con-
focal microscopy revealed that B. cenocepacia, BC7 and
isolate BCM132 colocalize with TNFR1 in primary human
mucociliary-differentiated airway epithelial cells, and in
the lungs of a CF patient who died due to B. cenocepacia
infection respectively. Taken together, these data suggest
that interaction of potentially virulent ET12 strains with
TNFR1 may contribute to the intense inflammation
observed in infected CF patients.
Tumour necrosis factor receptor 1 (TNFR1) belongs to a
superfamily of TNF receptors and plays an important role in
innate host defence (Pfeffer et al., 1993; Castanos-Velez
et al., 1998; Gomez et al., 2004; Hehlgans and Pfeffer,
2005). Binding of TNF-a to TNFR1 activates the NF-kB and
JNK pathways, leading to transcriptional activation of
genes encoding pro-inflammatory proteins, including IL-8
(Stanger et al., 1995; Hsu et al., 1996a; Wright et al.,
2004). Binding of TNF-a to TNFR1 may also activate the
caspase cascade, ultimately inducing apoptosis (Hsu
et al., 1996b). The inflammatory pathway deviates from the
apoptotic pathway very early in the signalling process.
Binding of TNF-a to TNFR1 induces trimerization and
recruitment of TRADD, which then recruits either RIP1 and
TRAF2 or FAS-associated death domain, activating
inflammatory or apoptotic pathways respectively (Baud
and Karin, 2001; Hehlgans and Pfeffer, 2005). We
observed that binding of B. cenocepacia to CF airway
epithelial cells did not induce apoptosis (data not shown);
Fig. 9. Effect of TNFR1 siRNA on transactivation of NF-kB by
B. cenocepacia BC7.
A. Transactivation of NF-kB by bacteria: IB3 cells were
co-transfected with NF-kB luciferase and renilla luciferase, and then
incubated with BC7, ATCC 25146 at a moi of 0.1 or TNF-a
(3 ng ml-1) for 24 h. Cells were lysed, and luciferase activity was
measured and expressed as fold increase over control.
B. Western blot analysis: IB3 cells were transfected with TNFR1-
specific or non-targeting siRNA, and incubated for 72 h. Cell lysates
were subjected to Western blot analysis with a TNFR1 antibody .
C. Inhibition of transactivation of NF-kB by TNFR1 siRNA: IB3 cells
were co-transfected with TNFR1-specific or non-targeting siRNA,
NF-kB luciferase and renilla luciferase, and incubated for 24 h. Cells
were serum starved overnight and then incubated with bacteria at a
moi of 0.1 or TNF-a (3 ng ml-1) for 24 h, and luciferase activity was
measured as before. Bars represent mean  SEM of six indepen-
dent experiments carried out in duplicates; *P < 0.05, ANOVA.
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rather, this interaction stimulated increased production of
IL-8. This effect was preceded by the recruitment of
TRADD and RIP1 to TNFR1 and phosphorylation of p38
and JNK, similar to cells treated with TNF-a, a natural
ligand for TNFR1. Neutralizing antibody to TNF-a did not
inhibit the production of IL-8 from IB3 cells incubated with
BC7, indicating that the observed effect was not mediated
by TNF-a. On the other hand, knockdown of TNFR1
expression by specific siRNA significantly attenuated
BC7-induced NF-kB transactivation. These observations
suggest that direct binding of BC7 to TNFR1 in CF cells is
required to activate a TNFR1-stimulated inflammatory sig-
nalling pathway.
The IL-8 response stimulated by B. cenocepacia may
not depend solely on the interaction of bacteria with
TNFR1. We and others have demonstrated that
B. cenocepacia also binds to other cellular receptors
(Sajjan et al., 2002; Reddi et al., 2003; Urban et al.,
2004). In the present study, our cell culture studies dem-
onstrated that approximately half of the bound bacteria
colocalized with TNFR1 receptor in both CF and non-CF
cells. Although TNF-a completely abrogated the binding
of BC7 to isolated TNFR1 in vitro, it only partially inhibited
the binding of BC7 to CF cells even at the highest con-
centration used. Similarly, blocking of TNFR1 expression
by TNFR1-specific siRNA partially repressed the NF-kB
transactivation associated with IL-8 production. Thus, the
capacity of BC7 to interact with TNFR1 may increase its
potential to stimulate pro-inflammatory response from CF
cells, but is not sufficient for the maximal response.
Although activation of TNFR1 plays a critical role in host
defence, pathogenic bacteria have evolved to utilize and
subvert this pathway to their advantage in susceptible
hosts. As we have shown for B. cenocepacia, Staphylo-
coccus aureus also has been shown to bind to TNFR1 in
airway epithelial cells and induce a TNFR1-related signal-
ling pathway, leading to NF-kB activation and IL-8 produc-
tion (Gomez et al., 2004). Protein A, a major surface
protein present in almost all strains of S. aureus, was
identified as a bacterial ligand. In a murine model of lung
infection, the interaction of protein A with TNFR1 resulted
in the mobilization of PMNs to airways, leading to severe
inflammation. Although recruitment of PMNs to airways is
a critical component of host defence, excessive and
repeated infiltration of PMNs can cause lung damage.
Previously we have shown that cable pili and the asso-
ciated 22 kDa adhesin are required to stimulate maximum
IL-8 production from squamous-differentiated bronchial
epithelial cells. Preliminary studies indicated that isogenic
mutants of BC7 lacking either cable pili or adhesin
retained their capacity to bind to TNFR1 (data not shown),
suggesting a role for yet another undefined bacterial
ligand. Identification and characterization of this bacterial
ligand is in progress.
Gene array analysis of CF airway epithelial cells
infected with P. aeruginosa points to increased expression
of TNF receptor and other related genes (Eidelman et al.,
2001). In the present study, we showed that expression of
TNFR1 is increased in cultured CF airway epithelial cells,
as well as in the lungs of CF patients. These observa-
tions implicate that chronic respiratory infection with
P. aeruginosa may, in fact, increase the expression of
TNFR1 in the lungs of CF patients. Thus, B. cenocepacia
ET12 strain, capable of binding to TNFR1 and activating
downstream signalling pathway may cause severe inflam-
mation in infected CF patients.
Experimental procedures
Bacterial strains and growth conditions
Burkholderia cenocepacia isolates BC7 and BC45 were obtained
from CF patients, and have been described previously (Sajjan
et al., 1992; 2002). Both BC7 and BC45 belong to ET12 lineage
and are indistinguishable by PFGE analysis and ribotyping, but
differ phenotypically. BC7, which was obtained from a patient
who died of ‘cepacia syndrome’, binds to mucin glycopeptides
and CK13, induces cell damage and a robust IL-8 response from
primary CF airway epithelial cells, and causes severe lung inflam-
mation and necrotizing pneumonia in CF mice. In contrast, BC45,
which was obtained from a patient with no apparent change in
disease severity, does not bind to mucin or cytokeratin 13, stimu-
lates low amounts of IL-8 from CF cells, and causes relatively
mild cell damage in vitro (Sajjan et al., 1992; 2000a; 2001a;
2002; 2004). BCM132 was isolated from post-mortem lungs of a
CF patient who died of cepacia syndrome, and also belongs to
ET12 lineage. ATCC 25416 is an environmental strain purchased
from the American Tissue Culture Collection (Manassas, VA).
Frozen stocks of BC7, BC45 and ATCC 25416 were subcultured
on BHI agar and incubated at 37°C for 24–36 h. A single colony
was inoculated into 10 ml tryptic soy broth and grown at 37°C for
12–16 h in the presence or absence of 35S-Translabel (GE
Healthcare, Mississauga, ON, Canada). Bacteria were harvested
by centrifugation, washed with PBS, and suspended in serum-
free cell culture media or PBS containing 1% bovine serum
albumin (BSA) to a desired concentration by measuring the
optical density at 600 nm (1 unit at OD600 corresponds to
~1 ¥ 109 cfu ml-1). In some experiments, bacteria were labelled
with FITC (Pierce Biotechnology, Rockford, IL) as described pre-
viously (Sajjan et al., 2000b).
Cell cultures
Cystic fibrosis and normal primary airway epithelial cells at
passage one were cultured at air/liquid interface as previously
described (Sajjan et al., 2004), and were kindly provided by Dr
Keshavjee (University Health Network, Toronto, Ontario,
Canada). Immortalized CF bronchial epithelial cells (IB3 cells)
(Zeitlin et al., 1991) were kindly provided by P. Zeitlin (Johns
Hopkins Medical Institute, Baltimore, Maryland). IB3 cells were
routinely grown in LHC-8 cell culture medium (Invitrogen, Carls-
bad, CA) supplemented with 2 mM glutamine, 5% fetal bovine
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serum, and 50 U ml-1 penicillin and 50 mg ml-1 streptomycin at
37°C in 5% CO2.
Binding assays
Bacterial overlay assay. Binding of bacteria to isolated plasma
membrane proteins was determined by a bacterial overlay assay
as described previously (Sajjan, 1993). Briefly, blots of CF airway
epithelial cell plasma membrane proteins were blocked with 1%
gelatin, washed and incubated with PBS-BSA containing
35S-labelled BC7 or BC45, or ATCC 25416. Blots were washed
with PBS-BSA to remove unbound bacteria, and bound bacteria
were detected by autoradiography. In some experiments, blots of
plasma membrane proteins were pre-incubated with TNF-a (R&D
Systems, Minneapolis, MN) or IL-1b. Autoradiographs were semi-
quantified using the ChemiDoc XRS system combined with
Quantity One 1-D analysis software (BIO-RAD Laboratories,
Hercules, CA).
Binding of bacteria to epithelial cells. IB3 cell monolayers grown
in six-well plates were lightly fixed with 0.5% paraformaldehyde
for 30 min and washed with PBS containing 0.5% BSA. FITC-
labelled bacteria were added to cells at a moi of 1, centrifuged at
200 g and incubated for 1 h at 37°C. Cells were washed with
PBS-BSA to remove unbound bacteria, and cells along with
bound bacteria were detached from the plate and analysed
with a Becton Dickinson FACSCalibur using CellQuest software.
The autofluorescence contributed by cells was subtracted from
all experimental samples. In inhibition assays, cells were pre-
incubated with potential inhibitors (TNF-a, or antibody to TNFR1)
for 1 h, washed with PBS and then incubated with FITC-labelled
bacteria. Cells incubated with normal IgG or IL-1b instead of
inhibitors served as negative controls.
Bacterial binding to cells by microscopy. Binding of bacteria to
IB3 cells was determined by quantitative immunofluorescence
microscopy as previously described (Sajjan et al., 2000a;
2002).
Identification of receptor protein
The plasma membrane-enriched fraction from primary CF airway
epithelial cells was subjected to SDS-PAGE and stained with
Coomassie blue. Protein bands at 55 kDa were cut out and
partially digested with trypsin. Peptides isolated from the gel were
subjected to peptide mapping and MS/MS sequencing with
Applied Biosystems/MDS Sciex API QSTAR XL MALDI QTOF
(Urban et al., 2004). Peptide fingerprinting of the in-gel digests
was analysed by database searching with ProFound (129.
85.19.192/profound_bin/WebProFound.exe), and the peptide
sequence obtained by MS/MS spectra was interpreted manually
and used to search for protein homologies (http://www.ncbi.nlm.
nih.gov/blast).
Infection of cell cultures
IB3 cells were shifted to serum- and antibiotic-free media for at
least 16 h prior to infection with bacteria. Bacteria were added to
cells at a moi of 0.1, 1 or 10 and centrifuged at 200 g, and
incubated as indicated in the Results section. Medium was col-
lected and centrifuged, and IL-8 present in the supernatants was
quantified by ELISA (R&D Systems). In some experiments, cells
were incubated with bacteria in the presence of neutralizing
antibody to TNF-a (R&D Systems, MN) or normal IgG. Well-
differentiated airway epithelial cell cultures were shifted to
antibiotic-free media at least 24 h prior to infection. Cultures were
incubated with ATCC 25416 or BC7 (1 ¥ 105 cfu equivalent to moi
of 0.1) apically for 24 h. Apical surface of cell cultures was
washed, embedded in agarose and fixed in 10% buffered forma-
lin, and finally embedded in paraffin as described previously
(Sajjan et al., 2002).
Detection of cell surface TNFR1 by flow cytometry
IB3 cells were incubated with monoclonal antibody specific to
TNFR1 or normal mouse IgG (matched isotype control) and
analysed by flow cytometry as previously described (Gomez
et al., 2004; Sajjan et al., 2006).
Immunoprecipitation and Western blot analysis
After relevant treatment, epithelial cells were washed and lysed in
ice-cold RIPA buffer containing complete protease inhibitors,
1 mM sodium orthovandate and 1 mM sodium fluoride. Cellular
proteins were resolved by SDS-PAGE and transferred to an
ImmobilonTM-P membrane (Millipore, Billerica, MA). Membranes
were probed with primary antibodies to phosphorylated or total
p38, JNK1, JNK2 (Cell Signaling Technology, Danvers, MA),
TNFR1, TRADD or RIP1 (Santa Cruz Biotechnology, Santa Cruz,
CA). Signals were amplified and visualized with horseradish
peroxidase-conjugated secondary antibodies (Bio-Rad Laborato-
ries) and chemiluminescent substrate (Pierce). Immunoprecipita-
tion of cell lysates with TNFR1 antibody was performed using
ExactaCruzTM B immunoprecipitation kit (Santa Cruz Biotechnol-
ogy) following the manufacturer’s instructions. Immunoprecipi-
tates were solubilized in reducing buffer and subjected to
Western blotting with either TRADD or RIP1 antibodies. Whole-
cell lysates were used to confirm the band position of TRADD and
RIP1 observed in the immunoprecipitates.
Transfection of cells and measurement of
NF-kB activation
IB3 cells grown in six-well plates were transiently transfected with
hNF-kB-luciferase (0.2 mg; Stratagene, La Jolla, CA) and renilla
luciferase (10 ng) using Lipofectamine 2000 (Invitrogen). The
following day, the cells were shifted to serum-free media and
stimulated with either B. cenocepacia BC7 at a moi of 0.1 or TNF-a
(3 ng ml-1). After incubation for 24 h, the cells were harvested and
luciferase activity was measured using a luminometer. Changes in
promoter activity were normalized for transfection efficiency by
dividing luciferase light units by renilla luciferase light units.
Results were then reported as fold increase over the empty
vector/untreated control. When siRNA was used to inhibit the
expression of TNFR1 protein, cells were transfected with 20 or
40 pmol of TNFR1 siRNA (Santa Cruz Biotechnology) along with
hNF-kB and renilla luciferase. Cells transfected with non-targeting
siRNA instead of TNFR1 siRNA was used as control.
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Immunofluorescence
Paraffin lung sections from a CF patient who succumbed to
cepacia syndrome was provided by Dr E. Tullis (University Health
Network, Toronto, Canada). Collection and utilization of lung
tissue was approved by the hospital ethics committee. Paraffin
section of non-CF lung was obtained from the pathology tissue
library at the Hospital for Sick Children, Toronto, Canada. Depar-
affinized and hydrated sections of lungs or primary airway epi-
thelial cell cultures were heated in 10 mM citric acid buffer under
pressure for 90 s to unmask the antigens and blocked with
normal donkey serum. Sections were incubated with a TNFR1
antibody or a mixture of TNFR1 antibody and antibody to
B. cepacia complex (R418) (Sajjan et al., 2001b), and the bound
antibodies were detected with anti-goat conjugated with Alexa
Fluor-488 (for detection of TNFR1) and anti-rabbit Alexa Flour-
598 (for detection of bacteria) (Molecular Probes, Portland, OR).
Sections were visualized by confocal fluorescent microscopy with
a Zeiss LSM 510 confocal microscope mounted on a Zeiss Axio-
vert 100 M inverted microscope. Optical sections at 0.2 m interval
were taken to assess the colocalization of bacteria with TNFR1
as described previously (Adamo et al., 2004; Gomez et al., 2004;
2005; 2007). Sections treated with normal IgG instead of primary
antibody served as negative controls.
Data analysis
Statistical significance was assessed by analysis of variance
(ANOVA). Differences identified by ANOVA were pinpointed by the
Tukey-Kramer test.
Acknowledgements
This work was supported by the grants from the Cystic Fibrosis
Foundation (SAJJAN06I0 to U.S.S. and LIPUMA97P0 to J.J.L.)
and the National Institutes of Health (HL82550 to M.B.H.). U.S.S.
was partially supported by the Carroll Hass Research Fund in
Cystic Fibrosis.
References
Adamo, R., Sokol, S., Soong, G., Gomez, M.I., and Prince, A.
(2004) Pseudomonas aeruginosa flagella activate airway
epithelial cells through asialoGM1 and toll-like receptor 2
as well as toll-like receptor 5. Am J Respir Cell Mol Biol 30:
627–634.
Bals, R., and Hiemstra, P.S. (2004) Innate immunity in
the lung: how epithelial cells fight against respiratory
pathogens. Eur Respir J 23: 327–333.
Baud, V., and Karin, M. (2001) Signal transduction by tumor
necrosis factor and its relatives. Trends Cell Biol 11: 372–
377.
Bryan, R., Kube, D., Perez, A., Davis, P., and Prince, A.
(1998) Overproduction of the CFTR R domain leads to
increased levels of AsialoGM1 and increased Pseudomo-
nas aeruginosa binding by epithelial cells. Am J Respir Cell
Mol Biol 19: 269–277.
Castanos-Velez, E., Maerlan, S., Osorio, L.M., Aberg, F.,
Biberfeld, P., Orn, A., and Rottenberg, M.E. (1998) Trypa-
nosoma cruzi infection in tumor necrosis factor receptor
p55-deficient mice. Infect Immun 66: 2960–2968.
De Soyza, A., McDowell, A., Archer, L., Dark, J.H., Elborn,
S.J., Mahenthiralingam, E., et al. (2001) Burkholderia
cepacia complex genomovars and pulmonary transplanta-
tion outcomes in patients with cystic fibrosis. Lancet 358:
1780–1781.
De Soyza, A., Morris, K., McDowell, A., Doherty, C., Archer,
L., Perry, J., et al. (2004a) Prevalence and clonality of
Burkholderia cepacia complex genomovars in UK patients
with cystic fibrosis referred for lung transplantation. Thorax
59: 526–528.
De Soyza, A., Ellis, C.D., Khan, C.M., Corris, P.A., and
Demarco de Hormaeche, R. (2004b) Burkholderia cenoce-
pacia lipopolysaccharide, lipid A, and proinflammatory
activity. Am J Respir Crit Care Med 170: 70–77.
Eidelman, O., Srivastava, M., Zhang, J., Leighton, X., Murtie,
J., Jozwik, C., et al. (2001) Control of the proinflammatory
state in cystic fibrosis lung epithelial cells by genes from
the TNF-alphaR/NFkappaB pathway. Mol Med 7: 523–534.
Epelman, S., Stack, D., Bell, C., Wong, E., Neely, G.G.,
Krutzik, S., et al. (2004) Different domains of Pseudomo-
nas aeruginosa exoenzyme S activate distinct TLRs.
J Immunol 173: 2031–2040.
Fink, J., Steer, J.H., Joyce, D.A., McWilliam, A.S., and
Stewart, G.A. (2003) Pro-inflammatory effects of Burkhold-
eria cepacia on cystic fibrosis respiratory epithelium. FEMS
Immunol Med Microbiol 38: 273–282.
Gomez, M.I., Lee, A., Reddy, B., Muir, A., Soong, G., Pitt, A.,
et al. (2004) Staphylococcus aureus protein A induces
airway epithelial inflammatory responses by activating
TNFR1. Nat Med 10: 842–848.
Gomez, M.I., Sokol, S.H., Muir, A.B., Soong, G., Bastien, J.,
and Prince, A.S. (2005) Bacterial induction of TNF-alpha
converting enzyme expression and IL-6 receptor alpha
shedding regulates airway inflammatory signaling.
J Immunol 175: 1930–1936.
Gomez, M.I., Seaghdha, M.O., and Prince, A.S. (2007) Sta-
phylococcus aureus protein A activates TACE through
EGFR-dependent signaling. EMBO J 26: 701–709.
Hehlgans, T., and Pfeffer, K. (2005) The intriguing biology of
the tumor necrosis factor/tumor necrosis factor receptor
superfamily: players, rules and the games. Immunology
115: 1–20.
Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel,
D.V. (1996a) TNF-dependent recruitment of the protein
kinase RIP to the TNF receptor-1 signaling complex. Immu-
nity 4: 387–396.
Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996b)
TRADD-TRAF2 and TRADD–FADD interactions define two
distinct TNF receptor 1 signal transduction pathways. Cell
84: 299–308.
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C.,
Fleming, P., and Levison, H. (1984) Pseudomonas cepacia
infection in cystic fibrosis: an emerging problem. J Pediatr
104: 206–210.
Kube, D., Sontich, U., Fletcher, D., and Davis, P.B. (2001)
Proinflammatory cytokine responses to P. aeruginosa
infection in human airway epithelial cell lines. Am J Physiol
Lung Cell Mol Physiol 280: L493–L502.
Ledson, M.J., Gallagher, M.J., Jackson, M., Hart, C.A., and
200 U. S. Sajjan, M. B. Hershenson, J. F. Forstner and J. J. LiPuma
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 10, 188–201
Walshaw, M.J. (2002) Outcome of Burkholderia cepacia
colonisation in an adult cystic fibrosis centre. Thorax 57:
142–145.
Moll, R., Franke, W.W., Schiller, D.L., Geiger, B., and
Krepler, R. (1982) The catalog of human cytokeratins: pat-
terns of expression in normal epithelia, tumors and cultured
cells. Cell 31: 11–24.
Nagle, R.B., Moll, R., Weidauer, H., Nemetschek, H., and
Franke, W.W. (1985) Different patterns of cytokeratin
expression in the normal epithelia of the upper respiratory
tract. Differentiation 30: 130–140.
Palfreyman, R.W., Watson, M.L., Eden, C., and Smith, A.W.
(1997) Induction of biologically active interleukin-8 from
lung epithelial cells by Burkholderia (Pseudomonas)
cepacia products. Infect Immun 65: 617–622.
Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakeham, A.,
Kishihara, K., Shahinian, A., et al. (1993) Mice deficient for
the 55 kd tumor necrosis factor receptor are resistant to
endotoxic shock, yet succumb to L. monocytogenes
infection. Cell 73: 457–467.
Reddi, K., Phagoo, S.B., Anderson, K.D., and Warburton, D.
(2003) Burkholderia cepacia-induced IL-8 gene expression
in an alveolar epithelial cell line: signalling through CD14
and mitogen-activated protein kinase. Pediatr Res 54:
297–305.
Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozma-
hel, R., Grzelczak, Z., et al. (1989) Identification of the
cystic fibrosis gene: cloning and characterization of
complementary DNA. Science 245: 1066–1073.
Rommens, J.M., Iannuzzi, M.C., Kerem, B., Drumm, M.L.,
Melmer, G., Dean, M., et al. (1989) Identification of the
cystic fibrosis gene: chromosome walking and jumping.
Science 245: 1059–1065.
Sajjan, U.S., and Forstner, J.F. (1993) Role of a 22-kilodalton
pilin protein in binding of Pseudomonas cepacia to buccal
epithelial cells. Infect Immun 61: 3157–3163.
Sajjan, U.S., Corey, M., Karmali, M.A., and Forstner, J.F.
(1992) Binding of Pseudomonas cepacia to normal human
intestinal mucin and respiratory mucin from patients with
cystic fibrosis. J Clin Invest 89: 648–656.
Sajjan, U.S., Sylvester, F.A., and Forstner, J. (2000a) Cable-
piliated Burkholderia cepacia bind to cytokeratin 13 of epi-
thelial cells. Infect Immun 68: 1787–1795.
Sajjan, U., Wu, Y., Kent, G., and Forstner, J. (2000b) Pref-
erential adherence of cable-piliated Burkholderia cepacia
to respiratory epithelia of CF knockout mice and human
cystic fibrosis lung explants. J Med Microbiol 49: 875–
885.
Sajjan, U., Thanassoulis, G., Cherapanov, V., Lu, A., Sjolin,
C., Steer, B., et al. (2001a) Susceptibility of Cftr (–/–) mice
to pulmonary infection with Burkholderia cepacia. Infect
Immun 69: 5138–5150.
Sajjan, U., Corey, M., Humar, A., Tullis, E., Cutz, E., Acker-
ley, C., and Forstner, J. (2001b) Immunolocalization of
Burkholderia cepacia in the lungs of cystic fibrosis patients.
J Med Microbiol 50: 535–546.
Sajjan, U., Ackerley, C., and Forstner, J. (2002) Interaction
of cblA/Adhesin-positive Burkholderia cepacia with squa-
mous epithelium. Cell Microbiol 4: 73–86.
Sajjan, S., Keshavjee, S., and Forstner, J. (2004)
Responses of well-differentiated airway epithelial cell cul-
tures from healthy donors and patients with cystic fibrosis
to Burkholderia cenocepacia infection. Infect Immun 72:
4188–4199.
Sajjan, U.S., Jia, Y., Newcomb, D.C., Bentley, J.K., Lukacs,
N.W., LiPuma, J.J., and Hershenson, M.B. (2006) H. influ-
enzae potentiates airway epithelial cell responses to rhi-
novirus by increasing ICAM-1 and TLR3 expression.
FASEB J 20: 2121–2123.
Shaw, D., Poxton, I.R., and Govan, J.R. (1995) Bio-
logical activity of Burkholderia (Pseudomonas) cepacia
lipopolysaccharide. FEMS Immunol Med Microbiol 11:
99–106.
Soong, G., Reddy, B., Sokol, S., Adamo, R., and Prince, A.
(2004) TLR2 is mobilized into an apical lipid raft receptor
complex to signal infection in airway epithelial cells. J Clin
Invest 113: 1482–1489.
Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., and Seed, B.
(1995) RIP: a novel protein containing a death domain that
interacts with Fas/APO-1 (CD95) in yeast and causes cell
death. Cell 81: 513–523.
Urban, T.A., Griffith, A., Torok, A.M., Smolkin, M.E., Burns,
J.L., and Goldberg, J.B. (2004) Contribution of Burkhold-
eria cenocepacia flagella to infectivity and inflammation.
Infect Immun 72: 5126–5134.
Wright, T.W., Pryhuber, G.S., Chess, P.R., Wang, Z., Notter,
R.H., and Gigliotti, F. (2004) TNF receptor signaling con-
tributes to chemokine secretion, inflammation, and respi-
ratory deficits during Pneumocystis pneumonia. J Immunol
172: 2511–2521.
Zeitlin, P.L., Lu, L., Cutting, G., Stetten, G., Kieffer, K.A.,
Craig, R., and Guggino, W.B. (1991) A cystic fibrosis bron-
chial epithelial cell line: immortalization by adeno-12-SV40
infection. Am J Respir Cell Mol Biol 4: 313–319.
Zughaier, S.M., Ryley, H.C., and Jackson, S.K. (1999)
Lipopolysaccharide (LPS) from Burkholderia cepacia is
more active than LPS from Pseudomonas aeruginosa and
Stenostrophomonas maltophilia in stimulating tumor necro-
sis factor alpha from human monocytes. Infect Immun 67:
1505–1507.
Interaction of B. cenocepacia with TNFR1 201
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 10, 188–201
